arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Lite Strategy, Inc.

LITS Health Care Biotechnology: Pharmaceutical Preparations
$1.18
▼ -5.2% Today
as of Oct 23, 12:04 ET
Last 30 days +2.17% Sep 14 → Oct 23
$0.99 $1.11 $1.23 $1.35 $1.47 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.21
High
$1.23
Low
$1.18
Volume
$167,815
Avg Vol
$445,633
Mkt Cap
$42M
P/E (TTM)
—
Beta
—
52w High
$2.26
52w Low
$0.69
Div Yield
—
Shares Out
$35M

LITS earnings at a glance

The options market is pricing a move of about ±221.3% after the report, a range of roughly -$1.43 to $3.79 from today's $1.18. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.8% on average; after the most recent report on May 13, 2026 it moved -5.6%. That means options currently expect more movement than LITS has typically delivered. Implied volatility is currently 19%. The share price of $1.18 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.69
$2.26
31% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-2.8%
0% positive
Latest IV / EM
1874%
EM ±221.3% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.49$0.25$2.99$5.72$8.46 Actual $-2.49Actual $1.54Actual $-2.32Actual $8.46Actual $-1.66Actual $-1.37Actual $-1.20Actual $-0.40Actual $-0.39Actual $-0.12Actual $-0.82Actual $-0.66 SepDecMarSepDecMarSepDecMar/2025Sep/2025DecMar/2026
Revenue vs Net Income Revenue Net income
$-31M$-24M$-17M$-10M$-3M Sep 24Dec 24Mar 25Sep 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.66 — — -69.2% -5.6% earnings
Wed Dec 31, 2025Dec 2025 $-0.82 — — — — financials
Fri Nov 14, 2025Sep/2025 $-0.12 — — — — earnings
Tue May 13, 2025Mar/2025 $-0.39 — — — 0.0% earnings
Tue Dec 31, 2024Dec 2024 $-0.40 — — — — financials
Mon Sep 30, 2024Sep 2024 $-1.20 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.37 — — — — financials
Sun Dec 31, 2023Dec 2023 $-1.66 — — — — financials
Sat Sep 30, 2023Sep 2023 $8.46 — — — — financials
Fri Mar 31, 2023Mar 2023 $-2.32 — — — — financials
Sat Dec 31, 2022Dec 2022 $1.54 — — — — financials
Fri Sep 30, 2022Sep 2022 $-2.49 — — — — financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue————$0$0$0—
Cost of revenue————————
Gross profit————————
Operating income$-22M$-30M$-4M—$-3M$-3M$-8M—
Net income$-24M$-31M$-4M—$-3M$-3M$-8M—
EPS (diluted)$-0.66$-0.82$-0.12—$-0.39$-0.40$-1.20—

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$8M$9M$10M$18M$20M$24M$7M$4M
Inventory————————
Total current assets$11M$11M$13M$18M$21M$24M$28M$41M
Total assets$58M$83M$113M$18M$21M$24M$28M$41M
Long-term debt————————
Total liabilities$952,000$1M$1M$1M$1M$2M$3M$8M
Total equity$57M$82M$112M$17M$20M$22M$25M$33M

Implied volatility — last 90 days

480%2808%5137%7465%9793% Jun 07 — IV 5303% · EM ±734.5%Jun 08 — IV 3561% · EM ±470.3%Jun 09 — IV 3694% · EM ±462.8%Jun 10 — IV 7050% · EM ±832.8%Jun 11 — IV 2997% · EM ±331.2%Jun 12 — IV 4814% · EM ±492.5%Jun 16 — IV 6165% · EM ±364.1%Jun 17 — IV 7685% · EM ±320.9%Jun 19 — IV 3225% · EM ±712.7%Jun 22 — IV 1795% · EM ±374.8%Jun 24 — IV 1859% · EM ±372.3%Jun 25 — IV 2030% · EM ±397.7%Jun 29 — IV 2017% · EM ±357.4%Jun 30 — IV 1983% · EM ±341.5%Jul 01 — IV 1296% · EM ±216.5%Jul 02 — IV 1984% · EM ±320.9%Jul 03 — IV 2054% · EM ±320.9%Jul 07 — IV 2534% · EM ±334.6%Jul 08 — IV 2655% · EM ±332.7%Jul 10 — IV 2554% · EM ±282.2%Jul 13 — IV 4114% · EM ±343.6%Jul 14 — IV 4046% · EM ±292.7%Jul 15 — IV 5392% · EM ±318.5%Jul 16 — IV 7527% · EM ±314.4%Jul 20 — IV 2055% · EM ±485.4%Jul 21 — IV 1290% · EM ±300.0%Jul 22 — IV 1295% · EM ±296.1%Jul 23 — IV 2242% · EM ±504.1%Jul 24 — IV 1396% · EM ±308.6%Jul 27 — IV 1496% · EM ±312.3%Jul 28 — IV 1587% · EM ±324.7%Jul 29 — IV 1601% · EM ±320.6%Jul 31 — IV 3184% · EM ±609.4%Aug 03 — IV 1697% · EM ±300.7%Aug 04 — IV 1906% · EM ±328.3%Aug 05 — IV 1410% · EM ±235.5%Aug 06 — IV 2096% · EM ±339.1%Aug 07 — IV 2292% · EM ±358.1%Aug 10 — IV 2738% · EM ±379.3%Aug 13 — IV 3030% · EM ±358.0%Aug 14 — IV 3420% · EM ±377.9%Aug 18 — IV 4781% · EM ±345.8%Aug 19 — IV 5494% · EM ±324.5%Aug 20 — IV 7487% · EM ±312.7%Aug 24 — IV 1139% · EM ±237.9%Aug 25 — IV 1280% · EM ±261.9%Aug 26 — IV 1508% · EM ±302.1%Aug 27 — IV 1506% · EM ±295.0%Aug 28 — IV 1679% · EM ±321.3%Aug 31 — IV 1747% · EM ±309.5%Sep 01 — IV 1782% · EM ±306.8%Sep 02 — IV 1849% · EM ±308.8%Sep 03 — IV 1727% · EM ±279.4%Sep 04 — IV 1600% · EM ±250.0%Sep 07 — IV 1805% · EM ±250.0%Sep 08 — IV 2031% · EM ±268.2%Sep 09 — IV 2221% · EM ±278.3%Sep 10 — IV 2196% · EM ±259.4%Sep 11 — IV 2161% · EM ±238.7%Sep 14 — IV 2655% · EM ±221.7%Sep 15 — IV 6722% · EM ±486.2%Sep 16 — IV 9794% · EM ±578.4%Sep 17 — IV 6677% · EM ±278.8%Sep 21 — IV 2083% · EM ±435.0%Sep 22 — IV 1917% · EM ±392.3%Sep 24 — IV 1821% · EM ±356.6%Sep 25 — IV 481% · EM ±92.0%Sep 29 — IV 799% · EM ±137.6%Sep 30 — IV 590% · EM ±98.5%Oct 01 — IV 1067% · EM ±172.7%Oct 02 — IV 1028% · EM ±160.7%Oct 06 — IV 1208% · EM ±159.6%Oct 07 — IV 1535% · EM ±192.4%Oct 08 — IV 1874% · EM ±221.3%

Sector peers

GRCE
Grace Therapeutics, Inc.
$43M $1.90-3.5%
NSRX
Nasus Pharma Ltd.
$40M $3.55+16.0%
VERU
Veru Inc.
$44M $2.27-1.3%
HOWL
Werewolf Therapeutics, Inc.
$45M $1.02-1.0%
EDSA
Edesa Biotech, Inc.
$46M $2.72-4.6%
FLNA
Filana Therapeutics, Inc.
$47M $0.64-2.9%

LITS earnings FAQ

What is LITS's expected move for earnings?

Options currently price a move of about ±221.3%, or $2.61 per share either way from $1.18.

How does LITS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.8%, up 0 times and down 2 times.

What is LITS's implied volatility?

LITS's at-the-money implied volatility is about 19% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in